Release Date: 2024-05-30

Treatment of Depression in Children and Adolescents

Neval Kizil (Author), Betul Uyar (Author)

Release Date: 2024-05-30

Depression is a prevalent disorder among children and adolescents, with significant rates of recurrence and suicide risk. The prevalence of Major Depressive Disorder varies by age and geography, with higher rates in adolescents and boys. Symptoms in children include depressed mood, irritability, and academic decline, while genetic and psychosocial factors increase risk. Effective treatment involves [...]

Media Type
    Buy from

    Price may vary by retailers

    Work TypeBook Chapter
    Published inDepression Treatment Updates
    First Page159
    Last Page175
    DOIhttps://doi.org/10.69860/nobel.9786053359456.9
    Page Count17
    Copyright HolderNobel Tıp Kitabevleri
    Licensehttps://nobelpub.com/publish-with-us/copyright-and-licensing
    Depression is a prevalent disorder among children and adolescents, with significant rates of recurrence and suicide risk. The prevalence of Major Depressive Disorder varies by age and geography, with higher rates in adolescents and boys. Symptoms in children include depressed mood, irritability, and academic decline, while genetic and psychosocial factors increase risk. Effective treatment involves psychoeducation, CBT, and pharmacotherapy, with SSRIs like fluoxetine being commonly used. Combining pharmacotherapy with CBT is most effective for moderate to severe cases. Resistant cases may require additional strategies such as venlafaxine, antipsychotics, or ECT. Family involvement is crucial for treatment compliance and motivation. Maintenance treatment should continue for 6-12 months post-remission to prevent relapse.

    Neval Kizil (Author)
    Research Assistant, Dicle University
    https://orcid.org/0009-0003-9865-7560
    3Dr. Neval Kızıl studied at Eskişehir Osmangazi Faculty of Medicine between 2014 and 2020. She graduated from Eskişehir Osmangazi Faculty of Medicine in 2020 and received the title of Medical Doctor. In 2020, she worked as a general practitioner at Diyarbakır Selahattin Eyyubi State Hospital as part of her compulsory service obligation. She started working as a child psychiatry assistant at İnönü University Faculty of Medicine between 2021-2023. As of 2023, she continues to work as a child psychiatry assistant at Dicle University Faculty of Medicine. He is a member of 1 organization related to his profession.

    Betul Uyar (Author)
    Associate Professor, Dicle University
    https://orcid.org/0000-0002-6428-1097
    3Associate Professor Betül Uyar graduated from Hacettepe University Faculty of Medicine in 2008. She received her psychiatry specialization from Dicle University Faculty of Medicine between 2011 and 2015. She has been a faculty member in the Department of Psychiatry, Dicle University Medical Faculty since 2019. Dr. Uyar, who has published many national and international articles, is a member of the Turkish Psychiatric Association.

    • Ye X, Bapuji SB, Winters S ve ark. (2014), Effectiveness of internet-based interventions for children, youth, and young adults with anxiety and/or depression; a systematic review and meta-analysis. BMC Health Serv Res 14:313

    • Rey JM, Bella Awusah TT, Liu J (2012) IACAPAP Textbook of Child and Adolescent Mental Health. Depression in children andadolescents. Chapter E.1 Mood Disorder

    • Bilac O. Ve ark., İlköğretim Öğrencilerinde Anksiyete ve Duygudurum Bozuklukları Yaygınlığı ve Sosyodemografik Özellikler. Türk Psikiyatri Dergidi, 2014. 25: s. 171-180.

    • Ercan, E. S., Polanczyk, G., Akyol Ardıc, U., Yuce, D., Karacetın, G., Tufan, A. E., ... & Tekden, M. (2019). The prevalence of childhood psychopathology in Turkey: a cross-sectional multicenter nationwide study (EPICPAT-T). Nordic Journal of Psychiatry, 73(2), 132-140.

    • APA, Diagnostic and Statistical Manual of Mental Disorders DSM-5. 2013, APP: Washington, DC.

    • Conner KR, Bossarte RM, Lu N ve ark. (2014) Parent and child psychopatology and suicide attempts among children and aparents with alcohol use disorder. Arc Suicide Res 18:117-130

    • Rao U(2013) Boamarkers in pediatric depression. Depress Anxiety A 30: 787-791

    • Philip H. Depression in children may go unnoticed and untreated. BMJ. 2002;325:229–230.

    • World Health Organization (2023). Addressing child and adolescent mental health. World Health Organization.

    • Cuijpers, P., Ebert, D. D., Acarturk, C., Andersson,G., & Cristea, I. A. (2016). Personalized Psychotherapy for Adult Depression: A Meta-Analytic Review. Behaviour therapy, 47(6), 966–980.

    • Muñoz, R. F., Cuijpers, P., Smit, F., Barrera, A. Z., & Leykin, Y. (2010). Prevention of major depression. Annual review of clinical psychology, 6181–6212.

    • Bellón, J.Á., Moreno-Peral, P., Motrico, E., Rodríguez-Morejón, A., Fernández, A., Serrano-Blanco, A., ... Conejo-Cerón, S. (2015). Effectiveness of psychological and/or educational interventions to prevent the onset of episodes of depression: A systematic review of systematic reviews and meta-analyses. Preventive Medicine, 76(S), S22–S32.

    • Conejo-Cerón, S., Moreno-Peral, P., Rodríguez-Morejón, A., Motrico, E., Navas- Campaña, D., Rigabert, A., ... Bellón, J.Á. (2017). Effectiveness of psychological and educational interventions to prevent depression in primary care: A systematic review and meta- analysis. Annals of Family Medicine, 15(3), 262–271.

    • Hetrick, S. E., Cox, G. R., Witt, K. G., Bir, J. J., & Merry, S. N. (2016). Cognitive behavioral therapy (CBT), third-wave CBT and interpersonal therapy (IPT) based interventions for preventing depression in children and adolescents. Cochrane Database of Systematic Reviews, 8.

    • Van Zoonen, K., Buntrock, C., Ebert, D. D., Smit, F., Reynolds, C. F., Beekman, A. T. F., & Cuijpers, P. (2014). Preventing the onset of major depressive disorder: A meta-ana- lytic review of psychological interventions. International Journal of Epidemiology, 43(2), 318–329.

    • Bhatia SK, Bhatia SC(2007) Childhood and adolescent depression. AM Fam Physician 75:73-80.

    • Cipriani A, Zhou X, Del Giovane C, Hetrick SE, Qin B, et al. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet 2016;388(10047)881–90,

    • Murray J, Cartwright-Hatton S. NICE guidelines on treatment of depression in childhood and adolescence: implications from a CBT perspective. Behav Cogn Psychother 2006;34(Feb (02))129. . [cited 2017 Dec 27],

    • Weisz JR, Kuppens S, Ng MY, Eckshtain D, Ugueto AM, et al. What five decades of research tells us about the effects of youth psychological therapy: a multilevel metaanalysis and implications for science and practice. Am Psychol 2017;72(2):79–117.

    • Effectiveness of CBT for children and adolescents with depression: A systematic review and meta-regression analysis Matthijs Ouda,*, Lars de Winterb, Evelien Vermeulen-Smitc, Denise Boddend, Maaike Nautae, Lisanne Stonef, Marieke van den Heuvelg, Reham Al Taherh, Ireen de Graafi, Tim Kendallj, Rutger Engelsk, Yvonne Stikkelbroekdd

    • Del Giovane CCS, Cipriani A. Combining Pharmacological and Nonpharmacological Interventions in Network Meta-analysis in Psychiatry. JAMA Psychiatry. 2019;0574.

    • Fristad MA, Vesco AT, Young AS, Healy KZ, Nader ES, Gardner W, et al. Pilot Randomized Controlled Trial of Omega-3 and Individual-Family Psychoeducational Psychotherapy for Children and Adolescents With Depression. J Clin Child Adolesc Psychol. 2019;48(sup1):S105–S18.

    • Kennard BD, Clarke GN, Weersing VR ve ark. (2009) Effective components of TORDİA cognitive-behavioral therapy for adolescent depression; Preliminary findings. J Consult Clin Physical 77: 1033-1041

    • Brenning K, Soenens B, Braet C, Bosmans G. The role of depressogenic personality and attachment in the intergenerational similarity of depressive symptoms: a study with early adolescents and their mothers Ghent, Belgium. 2011.

    • Davey CG, Chanen AM, Hetrick SE, Cotton SM, Ratheesh A, Amminger GP, et al. The addition of fluoxetine to cognitive behavioural therapyfor youth depression(YoDA-C): a randomised, double-blind, placebo- controlled, multicentre clinical trial. Lancet Psychiatry. 2019;6(9):735–44.

    • Cox GR, Callahan P, Churchill R, Hunot V, Merry SN, Parker AG, et al. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents. Cochrane Database Syst Rev. 2014;(11):CD008324.

    • Emslie Gj, Prakash A, Zhang Q ve ark(2014) A double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder. J Childe Adolesc Psychopharmacol 24:170-179

    • Hetrick SE, McKenzie JE, Cox GR, ve ark. (2012) Newer generation antidepressants for depressive disorders in children and adolescents . Cochrane Database of Systematic Reviews 11. Art. No: CD004851

    • Soutullo C, Figueroa-Quintana A (2013) When do you prescribe antidepressants to depressed children? Curt Psychiatry Rep 15:366.

    • Birmaher B, Brent D, AACAP Work Group on Quality Issues (2007) Practice parameter for assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 46: 1503-1526.

    • DeFillippis M, Wagner KD (2014) Management of treatment-resistant depression in children and adolescents. Paediatr Drugs 16: 353-361.

    • Emslie GJ, Kennard BD, Mayes TL ve ark. (2008) Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. AM J Psychiatry 165:459-467.

    • Yorbık, Özgür; Mutlu, Caner. Çocukluk ve Ergenlik Çağı Depresyonunda Seçici Serotonin Geri Alım İnhibitörlerinin Etkisi ve Güvenirliği : Bir Meta Analiz.

    • Çocuk ve Ergen Ruh Sağlığı ve Hastalıkları, Türkiye Çocuk ve Genç Psikiyatrisi Derneği Yayınları:9, 4. Baskı, 2021, sf: 160

    • Martynov O, Acharya N, Joliat M ve ark. (2004) Analysis of su- icidality in children and adolescents treated with fluoxetine. 51st Annual Meeting of the American Academy of Child and Adoles- cent Psychiatry, October 19-24 2004, Am Acad Child Adolesc Psychiatry.

    • Wagner KD, Robb AS, Findling RL ve ark. (2004) A randomized, placebocontrolled trial of citalopram for the treatment of major depression in children and adolescents. Am J Psychiatry 161(6): 1079-1083.

    • Emslie GJ, Wagner KD, Kutcher S ve ark. (2006) Paroxetine tre- atment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 45(6): 709-719.

    • Berard R, Fong R, Carpenter DJ ve ark. (2006) An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorder. J Child Adolesc Psychopharmacol 16(1-2): 59-75.

    • Emslie GJ, Findling RL, Yeung PP ve ark. (2007) Venlafaxine ER for the treatment of pediatric subjects with depression: Results of two placebo-controlled trials. J Am Acad Child Adolesc Psychiatry 46: 479-488

    • Çocuk ve Ergen Ruh Sağlığı ve Hastalıkları, Türkiye Çocuk ve Genç Psikiyatrisi Derneği Yayınları:9, 4. Baskı, 2021, sf: 161

    • DeFilippis M, Wagner KD (2014) Management of treatment-resistant depression in children and adolescents. PaediatrDrugs 16:353-361.

    • Soutullo C, Figueroa-Quintana A (2013) When do you prescribe antidepressants to depressed children? Curr Psychiatry Rep 15:366.

    • Wagner KD, Asarnow JR, Vitiello B ve ark. (2012) Out of the black box: treatment of resistant depression in adolescents and the antidepressant controversy. J Child Adolesc Psychopharmacol 22:5-10.

    • Malouf FT, Atwi M, Brent DA (2011) Treatment-resistant depression in adolescents: review and updates on clinical manage-ment. Depress Anxiety 28:946-954.

    • Schosser A, Kasper S (2009) The role of pharmacogenetics in the treatment of depression and anxiety disorders. Int Clin Psychopharmacol 24:277-288.

    • Wright BM, Eiland EH, Lorenz R ve ark. (2013) Augmentation with atypical antipsychotics for depression: a review of evidence-based support from the medical literature. Pharmacotherapy 33:344-359.

    • Magavi LR, Reti IM, Vasa RA (2017) A review of repetitive transcranial magnetic stimulation for adolescents with treatment- resistant depression. Int Rev Psychiatry 29(2):79–91

    • Zhand N, Courtney DB, FLament MF (2015) Use of electrocon- vulsive therapy in adolescents with treatment-resistant depressive disorders a case series. J Electroconvuls Ther 31:238–245

    • Cullen KR, Amatya P, Roback MG, Albott CS, Westlund Schreiner M, Ren Y, Eberly LE, Carstedt P, Samikoglu A, Gun- licks-Stoessel M, Reigstad K, Horek N, Tye S, Lim KO, Klimes- Dougan B (2018) Intravenous ketamine for adolescents with treatment-resistant depression: an open-label study. J Child Ado- lesc Psychopharmacol 28(7):437–444.

    • National Institute of Mental Health [NIMH] (1976) Clinical Global Improvement Scale and Clinical Global Assessment Scales. In: Edited by Guy W. ECDEU Assessment Manual for Psychopharmacology, revised. Rockville, ADM, pp 76– 338.

    • Kennard BD, Emslie GJ, Mayes TL ve ark. (2008) Cognitive-behavioral therapy to prevent relapse in pediatric responders to pharmacotherapy for major depressive disorder. Journal of the American Academy of Child Adolescent Psychiatry, 47(12): 1395-404.

    • Birmaher B ve Brent DA (2016) Depressive and Disruptive Mood Dysregulation Disorders. In: Dulcan MK (ed), Dulcan’s Textbook of Child and Adolescent Psychiatry. 2nd edition. American Psychiatric Association publishing, p. 245-270.

    • Çocuk ve Ergen Ruh Sağlığı ve Hastalıkları, Türkiye Çocuk ve Genç Psikiyatrisi Derneği Yayınları:9, 4. Baskı, 2021, sf: 158

    Share This Chapter!